Views | |
---|---|
A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response | 217 |
November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
---|---|---|---|---|---|---|---|
A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response | 1 | 0 | 2 | 8 | 1 | 1 | 2 |
Views | |
---|---|
2019_Denker_etal.pdf | 116 |